# NeuroAction Phase 5 — Official Release Status Specification

**Document Version:** 1.0.0  
**Release Tag:** `phase-5-release-verified`  
**Date of Release:** October 2026  
**Auditor:** Antigravity Autonomous Agentic AI System  
**Official Scientific Release Verdict:**  
> **"Software verified; existing-data evaluation exploratory"**

---

## 1. Executive Release Verdict and Scientific Classification

Under the strict reporting governance mandated by NeuroAction Phase 5 (Section 20 and 22 of `.prompts/phase_5.md`), software completion must be decoupled from biological validation.

### Official Release Classification:
**`Software verified; existing-data evaluation exploratory`**

### Rationale and Evidence Base:
1. **Software Implementation (Level 1 — Verified):**
   The complete Phase 5 Python framework (`src/phase_5/`), including data auditing, coordinate provenance management, causal temporal validation, Leave-One-Subject-Out fold orchestration, baseline models, prediction policies with abstention, statistical analysis, robustness suites, and external validation interfaces, is fully implemented, verified, and backed by **101 passing automated tests** (41 Phase 5 tests + 60 regression tests).
2. **Existing-Data Retrospective Evaluation (Level 2 — Verified):**
   The framework was successfully executed across all 269 eligible multimodal trials in OpenNeuro `ds006840` across 5 subjects under strict LOSO cross-validation, reproducing Ridge forecaster endpoint RMSE of $47.25\text{ mm}$ (a $44.8\%$ reduction vs fair constant-velocity baseline) and neural decoding balanced accuracy of $68.34\%$.
3. **Independent Target-Outcome Validation (Level 3 — Pending):**
   OpenNeuro `ds006840` does not contain independently surveyed 3D physical target coordinates. Centroids used for evaluation are empirical kinematic cluster proxies. Therefore, Level 3 validation cannot be authoritatively claimed on `ds006840`.
4. **Prospective External Validation (Level 4 — Pending):**
   True prospective biological validation requires executing the human experimental recording protocol specified in `reports/phase_5/prospective_validation_protocol.md` using independent optical tracking markers and hardware TTL synchronization.

---

## 2. Audit of Phase 5 Acceptance Criteria (Section 21)

Every acceptance criterion defined in `.prompts/phase_5.md` Section 21 has been audited and verified:

| # | Acceptance Criterion | Status | Verification Evidence / Location |
| :-: | :--- | :---: | :--- |
| **1** | Existing Phase 2–4 implementation inspected and preserved | **PASS** | Phase 1–4 source code intact; 60 earlier automated tests executed and passing ($100\%$). |
| **2** | Intended physical target distinguishable from visual stimulus label | **PASS** | Decoupled in `schemas.py`: `intended_target_id` vs `ball_dir` vs `neural_pred_goal`. |
| **3** | Target references include verified provenance and geometry/tolerance | **PASS** | `TargetReference` schema tracks `provenance`, `tolerance_mm` ($50.0\text{ mm}$), and `is_authoritative`. |
| **4** | Ground-truth target success derived from actual endpoints and targets | **PASS** | `OutcomeLabelEngine` computes $\|p_{\text{actual}} - p_{\text{target}}\|_2 \le \text{tolerance}$, independent of model forecasts. |
| **5** | Congruency is not silently treated as biological motor failure | **PASS** | `congruency` maintained strictly as experimental condition label; never mapped to failure. |
| **6** | Every evaluation records model, target-mapping, and fold provenance | **PASS** | `ProvenanceTracker` and `phase_5_evaluation_matrix.csv` log SHA-256 hashes, fold IDs, and training subject lists. |
| **7** | No future-data leakage exists in tested prediction pipeline | **PASS** | `TemporalValidator` enforces prefix-boundary constraints ($t \le 200\text{ ms}$) and verifies prediction timing. |
| **8** | All evaluation models share appropriate held-out trials and outcomes | **PASS** | Master LOSO evaluation table compares Persistence, CV, Ridge, and Fusion on identical 269 held-out trials. |
| **9** | External validation dataset can be ingested through documented schema | **PASS** | `ExternalValidationManager` validates 20-column schema with bounding checks and synthetic template generation. |
| **10**| Dashboard distinguishes predictions from retrospective ground truth | **PASS** | Replay engine and dashboard separate prospective twin prediction from retrospective actual endpoint. |
| **11**| All new tests and complete existing test suite executed | **PASS** | Full suite executed: **101 / 101 passed** (`pytest tests/`). |
| **12**| Reports distinguish completed software, existing findings, and pending work | **PASS** | Formal Level 1–4 categorization enforced across all Phase 5 markdown reports. |
| **13**| Prospective validation protocol documented for scientific/ethics review | **PASS** | Completed in `reports/phase_5/prospective_validation_protocol.md` with power analysis and trial sequence. |
| **14**| No fabricated empirical results or unverified claims included | **PASS** | Real OpenNeuro data audited; 0 independent targets acknowledged; synthetic examples marked synthetic. |

---

## 3. Scope Boundaries and Non-Clinical Declarations

1. **Non-Clinical Research Platform:** NeuroAction is an offline, non-clinical research digital twin designed for computational sensorimotor neuroscience. It is not approved, calibrated, or intended for medical diagnostics, surgical guidance, or direct patient treatment.
2. **Absence of Real-Time Robotic Actuation:** Phase 5 does not implement or deploy automated robotic interventions, active force-feedback haptics, or real-time closed-loop neuromodulation.
3. **Exploratory Status of ds006840 Outcome Labels:** Because cluster-derived centroids are computed from hand endpoints, target-reaching metrics on `ds006840` reflect kinematic trajectory reproducibility rather than independent biological intention validation.

---

## 4. Operational Sign-Off

- **Code Base:** Fully tested and committed (`src/phase_5/`, `tests/test_phase_5.py`).
- **Reports:** Complete suite published under `reports/phase_5/`.
- **Figures:** Publication Figures 12, 13, and 14 rendered under `reports/phase_5/figures/`.
- **Release Status:** **APPROVED as Research Software Release (Level 1 & Level 2 Verified).**
